MoneyWorks4Me

Anuh Pharma informs about change in directorate

22 Aug 2024 Evaluate
Anuh Pharma has informed that Sandeep Madhusudan Joshi (DIN: 00516409), has completed his second and final term as an Independent Director and consequently ceased to be a Director of the Company w.e.f. the closure of business hours on 21st August, 2024. The Board of Directors and the Management of the Company expressed deep appreciation and gratitude to Sandeep Madhusudan Joshi for his extensive contribution and stewardship. The details in respect of Sandeep Madhusudan Joshi, as required under SEBI Regulations read with SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated 13th July 2023 is given in Annexure A to this letter. The above information will also be available on the website of the Company at www.anuhpharma.com.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..